Dr. Enoch Akowuah and Dr. C. Michael Gibson Discuss: Minimally Invasive Versus Conventional Sternotomy For Mitral Valve Repair Surgery: An Expertise Based Multicentre Randomised Controlled Trial (UK Mini Mitral) March 5, 2023 Disclosures: TBD
Dr. Annapoorna Subhash Kini and Dr. C. Michael Gibson Discuss: Effect of Evolocumab on Coronary Plaque Characteristics in Stable Coronary Artery Disease: A Multimodality Imaging Study (the Yellow III Study) March 4, 2023 Disclosures: TBD
Dr. Divaka Perera and Dr. C. Michael Gibson Discuss: Effect of Myocardial Viability, Percutaneous Coronary Intervention and Functional Recovery on Clinical Outcomes in the REVIVED-BCIS2 Randomized Trial March 4, 2023 Disclosures: TBD
Dr. Javed Bulter, Dr. Rasha Al-Lamee and Dr. C. Michael Gibson Discuss: ACC 2023 ACCess Points Daily Wrap-up – March 4, 2023 March 4, 2023
Dr. Tomas Neilan, Dr. Marielle Scherrer-Crosbie, and Dr. C. Michael Gibson Discuss: Statins TO Prevent the Cardiotoxicity From Anthracyclines: The STOP-CA Trial March 4, 2023 Disclosures: TBD
Dr. Steven Nissen and Dr. C. Michael Gibson Discuss: Bempedoic Acid And Cardiovascular Outcomes In Statin Intolerant Patients At High Cardiovascular Risk March 4, 2023 Disclosures: TBD
This Week in Medicine®: Dr. Kausik Ray and Dr. C. Michael Gibson Discuss: Review of the Year in Prevention and Lipids December 27, 2022 Listen to Podcast Disclosures: TBD
This Week in Medicine®: Women are under-enrolled in clinical trials. Dr. Martha Gulati and I discuss how to increase participation of women in clinical trials. December 20, 2022 Listen to Podcast Disclosures: TBD
Snackable Health® with Dr. Gibson and Dr. Kohli: Did you know that there is another type of bad cholesterol? Dr. Payal Kohli and I talk about how earlier is better in a proactive approach to treating people with high levels of Lp(a) November 11, 2022 Disclosures: TBD
Snackable Health® with Dr. Gibson and Dr. Kohli: Are OTC fish oils that beneficial? Dr. Payal Kohli and I decipher the contradictory data regarding OTC fish oils November 11, 2022 Disclosures: TBD
